Research Article
Impact of Body Mass Index on Short-Term Outcomes in Patients Undergoing Percutaneous Coronary Intervention in Newfoundland and Labrador, Canada
Table 2
Medications at time of referral for PCI by BMI category.
| | | Total | NW | OW | OB | valu |
| | Number of patients | 6473 | 1073 | 2608 | 2792 | | | Beta blockers | 6431 | 863 (81.2) | 2154 (83.1) | 2318 (83.5) | | | ACE inhibitors | 6429 | 510 (48.0) | 1296 (50.0) | 1476 (53.2) | | | ARB antagonist | 6428 | 104 (9.8) | 305 (11.8) | 431 (15.5) | | | CCB | 6430 | 173 (16.3) | 433 (16.7) | 596 (21.5) | | | LA nitrates | 6430 | 307 (28.9) | 729 (28.1) | 869 (31.3) | | | Statin therapy | 6427 | 874 (82.3) | 2199 (84.9) | 2345 (84.5) | | | Aspirin | 6432 | 983 (92.5) | 2402 (92.6) | 2612 (94.1) | | | Ticlopidine/clopidogrel | 6432 | 806 (75.8) | 1846 (71.2) | 1925 (69.3) | | | Coumadin | 6429 | 15 (1.4) | 47 (1.8) | 59 (2.1) | | | GP IIb/IIIa inhibitors | 6437 | 5 (0.5) | 14 (0.5) | 13 (0.5) | | | LMWH | 6439 | 428 (40.2) | 971 (37.4) | 1003 (36.1) | | | IV heparin | 6439 | 220 (20.6) | 497 (19.1) | 579 (20.8) | | | IV nitrates | 6430 | 141 (13.3) | 313 (12.1) | 307 (11.1) | |
|
|
Values are presented as (%).
values for chi-squared tests.
ACE: angiotensin converting enzyme; ARB: angiotensin receptor blocker; BMI: body mass index; CCB: calcium channel blockers; LA nitrates: long-acting nitrates; LMWH: low molecular weight heparin; NW: normal weight; OB: obese; OW: overweight; PCI: percutaneous coronary intervention.
|
